Kathryn Ruddy

77PUBLICATIONS

535CO-AUTHORS

Predictive and prognostic markersChemotherapyMolecular targetsWomen's studies (incl. girls' studies)Cancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (77)

Sort by Publication Date:

|Jun 17, 2026

Factors Associated With Alcohol Intake in Patients With Newly Diagnosed Breast Cancer.

|May 27, 2026

Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain.

|Apr 29, 2026

Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

|Mar 03, 2026

Nationwide Mammographic Screening Among a Large Population of Underserved Subgroups.

Elizabeth J Cathcart-Rake, Viengneesee Thao, Jennifer Le-Rademacher

|Feb 13, 2026

Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study.

Pankaj Gupta, Kalpna Gupta, Travis Dockter

|Jan 26, 2026

Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.

Bradley J Stish, Gina L Mazza, Jones T Nauseef

Pageof 13

Frequent Collaborators

27 joint publications

Ann Partridge

13 joint publications

Shoshana Rosenberg

10 joint publications

Lidia Schapira

Virginia F Borges

Yue Zheng

Siddhartha Yadav

Fergus J Couch

Charles Loprinzi

Eric Winer

Janet E Olson

Frequent Collaborators

27 joint publications

Ann Partridge

13 joint publications

Shoshana Rosenberg

10 joint publications

Lidia Schapira

9 joint publications

Virginia F Borges